osimertinib
astrazeneca
['lung', 'herb', 'lcsm,(-blcsm)', 'osimertinib', 'adaura', 'nsclc', 'sclc', 'aura ,(-laura)']
narjust florez, md, and roy s. herbst, md, nsclc: overall survival analysis from the adaura trial of osimertinib #lcsm #lungcancer #oncology #asco23 
News and views from the world of clinical oncology and hematology